I posted this in another thread but thought it was worth creating a new thread for. Just found this link to a new interview with Roger Aston discussing the Phase 2 Canine trial. He discusses the trial, clarifies 'stable disease', the Elanco option, human trials and more. Very much worth a watch. Brings me more confidence to hear it from him personally.
https://www.youtube.com/watch?v=73rIH2s5Tbg&feature=youtu.be
If link doesn't work, type "PharmAust (ASX PAA) Q&A" into YouTube by the channel "TechInvest Magazine"
Roger Aston Interview May 2020
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $89.08M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $170.5K | 749.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34313 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 24444 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
-0.010 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.0¢ | 22.0¢ | 246904 | ||
| Last updated 15.57pm 14/06/2024 ? | |||||
| PAA (ASX) Chart |